876 related articles for article (PubMed ID: 24076358)
1. Ten years of dengue drug discovery: progress and prospects.
Lim SP; Wang QY; Noble CG; Chen YL; Dong H; Zou B; Yokokawa F; Nilar S; Smith P; Beer D; Lescar J; Shi PY
Antiviral Res; 2013 Nov; 100(2):500-19. PubMed ID: 24076358
[TBL] [Abstract][Full Text] [Related]
2. Development of specific dengue virus 2'-O- and N7-methyltransferase assays for antiviral drug screening.
Barral K; Sallamand C; Petzold C; Coutard B; Collet A; Thillier Y; Zimmermann J; Vasseur JJ; Canard B; Rohayem J; Debart F; Decroly E
Antiviral Res; 2013 Sep; 99(3):292-300. PubMed ID: 23769894
[TBL] [Abstract][Full Text] [Related]
3. Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.
Parkinson T; Pryde DC
Future Med Chem; 2010 Jul; 2(7):1181-203. PubMed ID: 21426163
[TBL] [Abstract][Full Text] [Related]
4. Strategies for development of Dengue virus inhibitors.
Noble CG; Chen YL; Dong H; Gu F; Lim SP; Schul W; Wang QY; Shi PY
Antiviral Res; 2010 Mar; 85(3):450-62. PubMed ID: 20060421
[TBL] [Abstract][Full Text] [Related]
5. The search for nucleoside/nucleotide analog inhibitors of dengue virus.
Chen YL; Yokokawa F; Shi PY
Antiviral Res; 2015 Oct; 122():12-9. PubMed ID: 26241002
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of dengue virus polymerase by blocking of the RNA tunnel.
Niyomrattanakit P; Chen YL; Dong H; Yin Z; Qing M; Glickman JF; Lin K; Mueller D; Voshol H; Lim JY; Nilar S; Keller TH; Shi PY
J Virol; 2010 Jun; 84(11):5678-86. PubMed ID: 20237086
[TBL] [Abstract][Full Text] [Related]
7. Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.
Smith TM; Lim SP; Yue K; Busby SA; Arora R; Seh CC; Wright SK; Nutiu R; Niyomrattanakit P; Wan KF; Beer D; Shi PY; Benson TE
J Biomol Screen; 2015 Jan; 20(1):153-63. PubMed ID: 25252731
[TBL] [Abstract][Full Text] [Related]
8. Small molecule inhibitor discovery for dengue virus protease using high-throughput screening.
Manzano M; Padia J; Padmanabhan R
Methods Mol Biol; 2014; 1138():331-44. PubMed ID: 24696346
[TBL] [Abstract][Full Text] [Related]
9. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
10. A Review on the Progress and Prospects of Dengue Drug Discovery Targeting NS5 RNA- Dependent RNA Polymerase.
Maddipati VC; Mittal L; Mantipally M; Asthana S; Bhattacharyya S; Gundla R
Curr Pharm Des; 2020; 26(35):4386-4409. PubMed ID: 32445444
[TBL] [Abstract][Full Text] [Related]
11. A high-throughput assay using dengue-1 virus-like particles for drug discovery.
Qing M; Liu W; Yuan Z; Gu F; Shi PY
Antiviral Res; 2010 May; 86(2):163-71. PubMed ID: 20153777
[TBL] [Abstract][Full Text] [Related]
12. A perspective on targeting non-structural proteins to combat neglected tropical diseases: Dengue, West Nile and Chikungunya viruses.
Bhakat S; Karubiu W; Jayaprakash V; Soliman ME
Eur J Med Chem; 2014 Nov; 87():677-702. PubMed ID: 25305334
[TBL] [Abstract][Full Text] [Related]
13. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis.
Wang QY; Bushell S; Qing M; Xu HY; Bonavia A; Nunes S; Zhou J; Poh MK; Florez de Sessions P; Niyomrattanakit P; Dong H; Hoffmaster K; Goh A; Nilar S; Schul W; Jones S; Kramer L; Compton T; Shi PY
J Virol; 2011 Jul; 85(13):6548-56. PubMed ID: 21507975
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the activity of 2'-C-methylcytidine against dengue virus replication.
Lee JC; Tseng CK; Wu YH; Kaushik-Basu N; Lin CK; Chen WC; Wu HN
Antiviral Res; 2015 Apr; 116():1-9. PubMed ID: 25614455
[TBL] [Abstract][Full Text] [Related]
16. Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies.
Arora R; Liew CW; Soh TS; Otoo DA; Seh CC; Yue K; Nilar S; Wang G; Yokokawa F; Noble CG; Chen YL; Shi PY; Lescar J; Smith TM; Benson TE; Lim SP
J Virol; 2020 Nov; 94(24):. PubMed ID: 32907977
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery.
Coutard B; Decroly E; Li C; Sharff A; Lescar J; Bricogne G; Barral K
Antiviral Res; 2014 Jun; 106():61-70. PubMed ID: 24704437
[TBL] [Abstract][Full Text] [Related]
18. An iminosugar with potent inhibition of dengue virus infection in vivo.
Perry ST; Buck MD; Plummer EM; Penmasta RA; Batra H; Stavale EJ; Warfield KL; Dwek RA; Butters TD; Alonzi DS; Lada SM; King K; Klose B; Ramstedt U; Shresta S
Antiviral Res; 2013 Apr; 98(1):35-43. PubMed ID: 23376501
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: Proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008.
Milligan GN; White M; Zavala D; Pyles RB; Sarathy VV; Barrett ADT; Bourne N
Antiviral Res; 2018 Jun; 154():104-109. PubMed ID: 29665374
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Potent Non-nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from Fragment Screening and Structure-Guided Design.
Lim SP; Noble CG; Nilar S; Shi PY; Yokokawa F
Adv Exp Med Biol; 2018; 1062():187-198. PubMed ID: 29845534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
